ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,710,380 | +26.9% | 90,881 | +7.3% | 0.19% | +26.8% |
| Q4 2022 | $1,347,867 | -26.6% | 84,665 | -24.6% | 0.15% | -23.5% |
| Q3 2022 | $1,836,000 | -38.8% | 112,239 | -47.3% | 0.20% | -32.4% |
| Q2 2022 | $3,002,000 | +460.1% | 213,094 | +863.4% | 0.30% | +410.3% |
| Q1 2022 | $536,000 | -75.6% | 22,118 | -83.3% | 0.06% | -65.5% |
| Q3 2021 | $2,196,000 | +747.9% | 132,205 | +1146.2% | 0.17% | +630.4% |
| Q2 2021 | $259,000 | -38.6% | 10,609 | -35.1% | 0.02% | -37.8% |
| Q1 2021 | $422,000 | -72.4% | 16,341 | -42.9% | 0.04% | -67.5% |
| Q4 2020 | $1,531,000 | – | 28,638 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |